hCLCA2 is a p53-inducible inhibitor of breast cancer cell proliferation

Cancer Research

Volumn 69, Issue 16, 2009, Pages 6624-6632

  Walia, Vijay ^a   Ding, Ming ^a,b   Kumar, Sumit ^a   Nie, Daotai ^a   Premkumar, Louis S ^a   Elble, Randolph C ^a,c  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CHLORIDE CHANNEL; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DOXORUBICIN; P21 ACTIVATED KINASE; PROTEIN P53;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL PH; CELL PROLIFERATION; CELL SURVIVAL; DNA DAMAGE; DOWN REGULATION; DRUG SENSITIVITY; GENE EXPRESSION PROFILING; GENE MUTATION; GENE REPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BINDING; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR SUPPRESSOR GENE; VIRAL GENE DELIVERY SYSTEM;

BASE SEQUENCE; BINDING SITES; BREAST NEOPLASMS; CELL PROLIFERATION; CELLS, CULTURED; CHLORIDE CHANNELS; DNA DAMAGE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HCT116 CELLS; HUMANS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 69249100045     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-4101     Document Type: Article

References (50)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
2. Vaziri H, West MD, Allsopp RC, et al. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO J 1997;16:6018-33.
3. Garbe JC, Holst CR, Bassett E, Tlsty T, Stampfer MR. Inactivation of p53 function in cultured human mammary epithelial cells turns the telomere-length dependent senescence barrier from agonescence into crisis. Cell Cycle 2007;6:1927-36.
4. Gewirtz DA. Growth arrest and cell death in the breast tumor cell in response to ionizing radiation and chemotherapeutic agents which induce DNA damage. Breast Cancer Res Treat 2000;62:223-35.
5. El-Deiry WS. The role of p53 in chemosensitivity and radiosensitivity. Oncogene 2003;22:7486-95.
6. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000;408:307-10.
7. Olivier M, Hussain SP, Caron de Fromentel C, Hainaut P, Harris CC. TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer. IARC Sci Publ 2004;157:247-70.
8. Langerod A, Zhao H, Borgan O, et al. TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer. Breast Cancer Res 2007;9:R30.
9. Wei CL, Wu Q, Vega VB, et al. A global map of p53 transcription-factor binding sites in the human genome. Cell 2006;124:207-19.
10. Yu J, Zhang L, Hwang PM, Rago C, Kinzler KW, Vogelstein B. Identification and classification of p53-regulated genes. Proc Natl Acad Sci U S A 1999;96: 14517-22.
11. Pauli BU, Abdel-Ghany M, Cheng HC, Gruber AD, Archibald HA, Elble RC. Molecular characteristics and functional diversity of CLCA family members. Clin Exp Pharmacol Physiol 2000;27:901-5.
12. Elble RC, Widom J, Gruber AD, et al. Cloning and characterization of lung-endothelial cell adhesion molecule-1 suggest it is an endothelial chloride channel. J Biol Chem 1997;272:27853-61.
13. Fuller CM, Ji HL, Tousson A, Elble RC, Pauli BU, Benos DJ. Ca(2+)-activated Cl(-) channels: a newly emerging anion transport family. Pflugers Arch 2001; 443 Suppl 1:S107-10.
14. Elble RC, Walia V, Cheng HC, et al. The putative chloride channel hCLCA2 has a single C-terminal transmembrane segment. J Biol Chem 2006;281:29448-54.
15. Bothe MK, Braun J, Mundhenk L, Gruber AD. Murine mCLCA6 is an integral apical membrane protein of nongoblet cell enterocytes and co-localizes with the cystic fibrosis transmembrane conductance regulator. J Histochem Cytochem 2008;56:495-509.
16. Gibson A, Lewis AP, Affleck K, Aitken AJ, Meldrum E, Thompson N. hCLCA1 and mCLCA3 are secreted nonintegral membrane proteins and therefore are not ion channels. J Biol Chem 2005;280:27205-12.
17. Huan C, Greene KS, Shui B, et al. mCLCA4 ER processing and secretion requires luminal sorting motifs. Am J Physiol Cell Physiol 2008;295:279-87.
18. Kunzelmann K. Ion channels and cancer. J Membr Biol 2005;205:159-73.
19. Lastraioli E, Guasti L, Crociani O, et al. herg1 gene and HERG1 protein are overexpressed in colorectal cancers and regulate cell invasion of tumor cells. Cancer Res 2004;64:606-11.
20. Sontheimer H. An unexpected role for ion channels in brain tumor metastasis. Exp Biol Med (Maywood) 2008;233:779-91.
21. Suh KS, Yuspa SH. Intracellular chloride channels: critical mediators of cell viability and potential targets for cancer therapy. Curr Pharm Des 2005;11:2753-64.
22. Elble RC, Pauli BU. Tumor suppression by a proapoptotic calcium-activated chloride channel in mammary epithelium. J Biol Chem 2001;276:40510-7.
23. Beckley JR, Pauli BU, Elble RC. Re-expression of detachment-inducible chloride channel mCLCA5 suppresses growth of metastatic breast cancer cells. J Biol Chem 2004;279:41634-41.
24. Gruber AD, Pauli BU. Tumorigenicity of human breast cancer is associated with loss of the Ca2+-activated chloride channel CLCA2. Cancer Res 1999;59:5488-91.
25. Li X, Cowell JK, Sossey-Alaoui K. CLCA2 tumour suppressor gene in 1p31 is epigenetically regulated in breast cancer. Oncogene 2004;23:1474-80.
26. Saramaki A, Banwell CM, Campbell MJ, Carlberg C. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res 2006;34:543-54.
27. Chang BD, Swift ME, Shen M, Fang J, Broude EV, Roninson IB. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc Natl Acad Sci U S A 2002;99:389-94.
28. Roninson IB. Tumor cell senescence in cancer treatment. Cancer Res 2003;63:2705-15.
29. Lehnhardt M, Klein-Hitpass L, Kuhnen C, et al. Response rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathways. BMC Cancer 2005;5:74.
30. Stegmaier K, Wong J, Ross K, et al. Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma. PLoS Med 2007;4:e122.
31. Aylon Y, Oren M. Living with p53, dying of p53. Cell 2007;130:597-600.
32. Xie X, Lu J, Kulbokas E, et al. Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature 2005;434: 338-45.
33. Watts GS, Oshiro MM, Junk DJ, et al. The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells. Neoplasia 2004;6:187-94.
34. Györffy B, Surowiak P, Kiesslich O, et al. Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int J Cancer 2006;118:1699-712.
35. Gottlieb RA, Dosanjh A. Mutant cystic fibrosis transmembrane conductance regulator inhibits acidification and apoptosis in C127 cells: possible relevance to cystic fibrosis. Proc Natl Acad Sci U S A 1996;93: 3587-91.
36. Szabo I, Lepple-Wienhues A, Kaba KN, Zoratti M, Gulbins E, Lang F. Tyrosine kinase-dependent activation of a chloride channel in CD95-induced apoptosis in T lymphocytes. Proc Natl Acad Sci U S A 1998;95: 6169-74.
37. Barriere H, Poujeol C, Tauc M, Blasi JM, Counillon L, Poujeol P. CFTR modulates programmed cell death by decreasing intracellular pH in Chinese hamster lung fibroblasts. Am J Physiol Cell Physiol 2001;281: C810-24.
38. Xiao H, Li T, Yang J, Liu L. Acidic pH induces topoisomerase II-mediated DNA damage. Proc Natl Acad Sci U S A 2003;100:5205-10.
39. Lang F, Föller M, Lang K, et al. Cell volume regulatory ion channels in cell proliferation and cell death. Methods Enzymol 2007;428:209-25.
40. Monastyrskaya K, Tschumi F, Babiychuk EB, Stroka D, Draeger A. Annexins sense changes in intracellular pH during hypoxia. Biochem J 2008;409:65-75.
41. Wang H, Zhang Y, Cao L, et al. HERG K+ channel, a regulator of tumor cell apoptosis and proliferation. Cancer Res 2002;62:4843-8.
42. Tang Y, Liu Y, Zhou J, Wang G, Qiu Q, Guan Y. Silence of ClC-3 chloride channel inhibits cell proliferation and the cell cycle via G/S phase arrest in rat basilar arterial smooth muscle cells. Cell Prolif 2008;41:775-85.
43. Fernández-Salas E, Suh K, Speransky V, et al. mtCLIC/CLIC4, an organellular chloride channel protein, is increased by DNA damage and participates in the apoptotic response to p53. Mol Cell Biol 2002;22: 3610-20.
44. Klebig C, Seitz S, Arnold W, et al. Characterization of {γ}-aminobutyric acid type A receptor-associated protein, a novel tumor suppressor, showing reduced expression in breast cancer. Cancer Res 2005;65:394-400.
45. Lagadic-Gossmann D, Huc L, Lecureur V. Alterations of intracellular pH homeostasis in apoptosis: origins and roles. Cell Death Differ 2004;11:953-61.
46. Musgrove E, Seaman M, Hedley D. Relationship between cytoplasmic pH and proliferation during exponential growth and cellular quiescence. Exp Cell Res 1987;172:65-75.
47. Furlong I, Ascaso R, Lopez Rivas A, Collins M. Intracellular acidification induces apoptosis by stimulating ICE-like protease activity. J Cell Sci 1997;110:653-61.
48. Zhao R, Oxley D, Smith TS, Follows GA, Green AR, Alexander DR. DNA damage-induced Bcl-xL deamidation is mediated by NHE-1 antiport regulated intracellular pH. PLoS Biol 2007;5:e1.
49. Monastyrskaya K, Tschumi F, Babiychuk E, Stroka D, Draeger A. Annexins sense changes in intracellular pH during hypoxia. Biochem J 2008;409:65-75.
50. Wang X, Venable J, LaPointe P, et al. Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 2006;127:803-15.